ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2026 Pediatric Rheumatology Symposium

March 18-21, 2026. Minneapolis, MN.

View by Number View by Title View Sessions
  • Abstract Number: 047

    Association of anti-DFS70 with autoimmune diseases in children
  • Abstract Number: 048

    Clinical characteristics of childhood-onset primary Sjögren’s syndrome in South Korea: two centers’ experiences
  • Abstract Number: 049

    Novel Insights of Brain MRI Features in Neonatal Lupus Erythematosus with Hydrocephalus
  • Abstract Number: 050

    The Quiet Beginning: Early Pediatric Systemic Lupus Erythematosus (SLE) Without Nephritis and the Path to Renal Involvement
  • Abstract Number: 051

    Do Changes in the Weather Influence Joint Pain and Stiffness in Children with Juvenile Idiopathic Arthritis?
  • Abstract Number: 052

    Case Series: Treatment of Refractory Lung Disease in Systemic Juvenile Idiopathic Arthritis with Cyclophosphamide and Rituximab Combination Therapy
  • Abstract Number: 053

    Association between Childhood Opportunity Index and Disparities in Health Care Access and Utilization in Childhood Onset Systemic Lupus Erythematosus
  • Abstract Number: 054

    Assessing Completion of Healthcare Transition: A Retrospective Review of Provider Acknowledgment Following Pediatric Rheumatology Transfer
  • Abstract Number: 055

    Referrals Leading to Rheumatologic Diagnosis in a Pediatric Rheumatology Center: Influence of Referring Provider Practice and Training
  • Abstract Number: 056

    Journey Maps of the Diagnostic Process: Insights from Caregivers of Patients with Juvenile Idiopathic Arthritis
  • Abstract Number: 057

    Pediatric Learners’ Knowledge Retention and Diagnostic Confidence after High-Fidelity Pediatric Rheumatology Simulation
  • Abstract Number: 058

    Increasing Reproductive Health Counseling and Screening in a Pediatric Rheumatology Clinic Using Quality Improvement Principles and Diverse Group of Stakeholders
  • Abstract Number: 059

    Use of Multimodal Teaching to Improve Resident Confidence in Evaluating Rheumatic Conditions
  • Abstract Number: 060

    Impact of Social Determinants of Health on Outcomes in Pediatric Uveitis
  • Abstract Number: 061

    Impacts of Social Drivers of Health on Outcomes for Patients with Pediatric Systemic Lupus Erythematosus
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology